Introduction
============

*Haemophilus parasuis* is a γ-proteobacteria, which belongs to the *Pasteurellaceae* family, is a rod-shaped, Gram-negative, non-motile, non-haemolytic, pleomorphic and nicotinamide adenine dinucleotide (NAD)-dependent bacterium [@B1], [@B2]. It is a commensal bacterium of the upper respiratory tract of healthy pigs [@B3], [@B4]. In conjunction with viral infections in immunocompromised animals, *H. parasuis* can transform into a pathogen responsible for causing Glasser\'s disease, which is typically characterized by fibrinous polyserositis, polyarthritis, meningitis and sometimes acute pneumonia and septicemia [@B3]-[@B5]. However, clinical signs of *H. parasuis* infection in diseased pigs are mostly non-specific. This disease is one of the primary causes of morbidity and mortality in the U.S. and swine industries worldwide, resulting in substantial economic losses.

To date, 15 different serovars of *H. parasuis* have been identified based on the presence of heat stable antigens and gel diffusion tests, although a high percentage of the field isolates are non-typable [@B6]. However, the highly discriminatory multilocus variable number of tandem repeats analysis (MLVA) may reduce the number of non-typable isolates [@B7]. Different serovars of *H. parsuis* exhibit different degrees of virulence, ranging from highly virulent to non-virulent. Of the 15 recognized serovars, *H. parasuis* serovar 5 is more frequently isolated from respiratory and systemic infection in pigs [@B8]. In addition, *H. parasuis* serovar 5 is one of the major causative agents of neonatal mortality in the pig industry worldwide [@B9]. During the past few years, Newport Laboratories has observed an increase in the number of cases of *H. parasuis* serovar 4 infections in the U.S. Recent surveys have also reported *H. parasuis*serovar 4 is an emerging pathogen in the U.S. with a potential to cause serious disease outbreaks [@B10].

Like other members of *Pasteurellaceae, H. parasuis* has a large number of virulence and virulence-associated genes. These include lipopolysaccharide (LPS), capsular polysaccharide, adhesins/fimbriae, outer membrane proteins, neuraminidase, iron and heavy metal acquisition and transport systems [@B3], [@B11], [@B12], [@B13], [@B14]. However, there is no direct correlation between the expression of these virulence factors and the virulence of *H. parasuis* isolates. In addition, the molecular basis underlying the expression of candidate virulence factors is not yet fully elucidated due to the complex gene regulatory mechanisms. Various serovars of *H. parasuis* exhibit a high heterogeneity at the molecular level, mostly due to recombination or lateral gene transfer.

We have isolated several highly virulent *H. parasuis* serovar 4 strains from the lungs of diseased pigs, which died of severe pneumonia and septicemia. Highly virulent *H. parasuis* strains can be opportunistic pathogens secondary to pneumonia, viral infection and/or stress causing septicemia without polyserositis or Glässer\'s disease which is characterized by polyserositis, pericarditis, arthritis and meningitis [@B3],[@B4],[@B5]. To understand the differences in virulence and virulence-associated genes between *H. parasuis* serovar 5 and highly virulent *H. parasuis* serovars 4 strains we performed a three-way comparative genomic analysis between two *H. parasuis* serovar 4 strains and a virulent *H. parasuis* serovar 5 a U.S. isolate.

Results and discussion
======================

Gene coverage and overall mapping
---------------------------------

The *H. parasuis* serovar 4 strains (serovar 4-1 and serovar 4-2) mapped approximately 90% to the reference strain a virulent *H. parasuis* serovar 5 isolate, indicating a very high homology. The assemblies analyzed were approximately 190 and 150 Kb in length and consisted of 194 and 149 contigs for *H. parasuis* serovar 4-1 and *H. parasuis* serovar 4-2 respectively to cover the entire genome. We obtained 255x, 300x and 200x coverage for virulent *H. parasuis* serovar 4-1, *H. parasuis* serovar 4-2 strains and *H. parasuis* serovar 5 WT respectively. The comparison criteria set for all the three strains was that open reading frames (ORFs) having \<80% overall base coverage were called absent. Among 2456 ORFs identified, approximately 919 were hypothetical proteins and 2328 ORFs were common to all the three strains. There were 83 genes unique to the virulent *H. parasuis* serovar 5, 26 genes unique to *H. parasuis* serovar 4-1, and 48 genes unique to *H. parasuis* serovar 4-2 (Figure [1](#F1){ref-type="fig"}). The list of individual genes unique to each isolate is summarized in [Supplementary Material](#SM1){ref-type="supplementary-material"}: Table 2. Both *H. parasuis* serovar 4 strains lacked enzymes such as UDP-glucose-4-epimerase, \'toxin-antitoxin system" and a large number of hypothetical proteins which were present in *H. parausis* serovar 5. However, the genes involved in altering the outer membrane protein (OMP) and lipooliosaccharide (LOS) structure are sialyltransferase, glycosyl transferases, polysaccharide biosynthesis protein capD, spore coat polysaccharide biosynthesis protein C and polysaccharide export protein were present and analyzed. These proteins are involved in serovar determination, immune evasion and act as virulence factors. In addition, *H. parasuis* serovar 4-1 and serovar 4-2 contain genes which encode other virulence and virulence associated factors found in the "wild type" *H. parasuis* serovar 5. The genomes of *H. parasuis* serovar 4 strains have been deposited at DDBJ/EMBL/GenBank® under the accession numbers JJNQ00000000 (serovar 4-1), JJNR00000000 (serovar4-2). The version described in this paper is JJNQ00000000.1 and JJNR00000000.1.

Sialyltransferase
-----------------

Sialylation of LOS has been implicated as a bacterial virulence factor involved in inhibiting antibody binding and enhancing bacterial serum resistance [@B16], [@B17]. The genes encoding α-2, 3-sialyltransferases are involved in LOS biosynthesis in pathogenic members of the *Pasteurellaceae* family such as *Neisseria gonorrheae*, *Haemophilus ducreyi*, *Haemophilus influenzae* and *Histophilus somni* [@B17],[@B18]. Sialylated LOS aids host-immune evasion by molecular mimicry. Some pathogenic bacteria also utilize linkage-specific sialyltransferases like, α-2, 3 linkages to galactose, or α-2, 6 linkages to galactose or N-acetylgalactosamine to sialylate the LOS to avoid host innate defense mechanisms [@B17]. Sialylated LOS have been reported to induce significantly less cytokine response from macrophages by inhibiting the TLR-4 signaling pathway, which in turn induces significantly less transcription factor NF-κB than de-sialylated LOS [@B19],[@B20].

Sialyltransferase-encoding gene (*lsgB*) is known to be present only in virulent *H. parasuis* strains, which also display an increased resistance to serum-mediated killing and phagocytosis by alveolar macrophages than strains lacking *lsgB* [@B21]. However, pigs infected with variant *H. parasuis* serovar 4 exhibited signs of acute pneumonia and septicemia indicating a possible "cytokine storm" as a result of infection. Furthermore, in piglet challenge experiments, *H. parasuis* serovar 4 was the dominant species recovered from the tissue samples. When mice were injected with a de-sialylated *H. parasuis*serovar 4 mutant all the mice died within 48 h due to septicemia, indicating an exuberant immune response. In contrast, mice injected with sialylated (wild type) *H. parasuis* serovar 5 did not die, but had injection site swelling. Providing further evidence for the lack of involvement of the sialyltransferase gene in virulence and evidence that some *H. parasuis* serovar 4 strains may have alternate pathways for adding sialic acid to proteins and polysaccharides.

*Haemophilus parasuis* serovar 4 and serovar 5 lack specific *de novo* sialic acid biosynthesis genes, but the genome encodes two tripartite ATP-independent periplasmic transporters, Neu5Ac TARP (HPM_1229, HPM_0026), TRAP permease (HPM_0027) and CMP-Neu5 Ac synthetase gene (HPM_0608), acylneuraminate cytidylyltransferase (HPM_1673) indicating the presence of a sialic acid scavenge mechanism similar to that of *H. influenza*and synthesis of CMP-Neu5Ac [@B17]. Since the variant *H. parasuis* serovar 4 lacks α-2, 3-sialyltransferases, we hypothesized that the amount of sialic acid coupled to LOS should be less than serovar 5. The amount of sialic acid coupled to LOS was determined after treating the cells with neuraminidase and the *H. parasuis* serovar 4 strains had significantly less sialic acid residues linked to LOS when compared to serovar 5 WT (Fig [2](#F2){ref-type="fig"}).

These results contradict the current thinking that sialic acid is necessary for *H. parasuis* virulence. The variant *H. parasuis* serovar 4 strains possess other virulence factors that help subvert host-immune response and aid in pathogenesis.

Glycosyl transferases
---------------------

The variant*H. parasuis* serovar 4-1 and serovar 4-2 strains lack four glycosyl transferases (HPM_1373, HPM_1372 and HPM_1370 and HPM_1371). Glycosyl transferases catalyze the reaction involving the addition of carbohydrate side group to a protein or lipid molecule. Addition of carbohydrate residues to proteins significantly alter biophysical and structural properties such as the solubility index, resistance to proteases, stability, protein-protein interactions and most importantly the immunogenicity of pathogenic bacteria [@B22]-[@B26].

The lack of glycosyl transferases among the variant*H. parasuis* serovar 4 strains suggests the existence of an alternate pathway for glycosylation as different groups of glycosyl transferases have overlapping functions. Many enzymes involved in cell wall biosynthesis like N-acetylmuramyl-tripeptide synthetase protein (HPM_1513), MurNAc-pentapeptide synthetase (HPM_1514), phospho-N-acetylmuramoyl-pentapeptide-transferase (HPM_1515), UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase (HPM_1945), D-alanine-D-alanine ligase (HPM_2304), UDP-3-O-acyl-N-acetylglucosamine deacetylase (HPM_2413) and exopolysaccharide biosynthesis protein (HPM_0770) are identical across all three strains. A complete list of serovar 4 genes is provided in [Supplementary Material](#SM1){ref-type="supplementary-material"}: Table 3. Modified LOS and OMP glycosylation pattern of variant *H. parasuis* serovar 4 strains most likely help the bacterium avoid phagocytosis.

Polysaccharide export protein and polysaccharide biosynthesis protein CapD
--------------------------------------------------------------------------

Polysaccharide export protein and polysaccharide biosynthesis protein are located as contiguous ORFs in *H. parasuis* serovar 4 and serovar 5 strains. Bacteria export extracellular polysaccharides (EPS) and capsular polysaccharides (CPS) through complex network of transport systems [@B27]. These biopolymers have various biological functions, such as providing reserve material or as part of the cell protective structure, and can provide an advantage for pathogenic bacteria under certain environmental conditions.

In pathogenic bacteria, production and export of EPS and CPS poses a major challenge as these high-molecular-weight hydrophilic polymers must be assembled and exported across the envelope, without compromising the essential functional properties of the envelope [@B27]. Two major pathways with different polymer biosynthesis strategies are employed by bacteria in the assembly of most EPS/CPS: the Wzy-dependent and ATP-binding cassette (ABC) transporter-dependent pathways [@B28]. They converge in an outer membrane export step mediated by a member of the outer membrane auxiliary (OMA) protein family. Outer membrane auxiliary proteins form outer membrane efflux channels for the biopolymers. The polysaccharide co-polymerase (PCP) family of enzymes interacts with OMA proteins forming a trans-envelope scaffold for polymer export [@B28]. The variant *H. parasuis*serovar 4 strains have numerous ABC transporter systems similar to virulent *H. parasuis* serovar 5 but lack the polysaccharide export protein (HPM_0299) *wza*which reveals a functional overlap between ABC transporters in exporting complex carbohydrates and biopolymers.

The *cap*D gene (HPM_0300) encodes a polysaccharide biosynthesis protein which has been implicated in *H. parasuis* virulence. However, a characteristic feature of this gene that is associated with the pathogenicity of *H. parasuis* is not understood [@B29]. This domain is found in diverse bacterial polysaccharide biosynthetic proteins including the WalL protein, mannosyl-transferase and epimerases [@B30]. The CapD protein is required for biosynthesis of type 1 capsular polysaccharide in *Staphylococcus* spp. [@B31] and serum-resistance in *H. parasuis* [@B32]. Despite lacking this domain the variant *H. parasuis*serovar 4-1 and serovar 4-2 strains are highly virulent and were recovered in pure cultures from experimentally infected dead pigs, possibly supporting serum-resistance and virulence without the capD protein.

Earlier reports indicate that the deletion of capD gene significantly attenuates *H. parasuis* serotype 5 SH0165 (GenBank No. CP001321.1) pathogenicity and the complementation of this gene restored the pathogenicity in piglets [@B32]. In addition, the capD deleted *H. parasuis* serotype 5 SH0165 strains were not recovered from challenged piglets. However, both*H. parasuis* serotype 5 SH0165 wild type and complemented-capD strains were recovered from most of the systemic sites [@B32]. The variant *H. parasuis* serovar 4 strains caused a rapid onset of clinical signs and death (50% mortality) in experimentally infected pigs. Necropsy of the dead pigs revealed lung lesions typical of *H. parasuis*serovar 4 and isolation of the original challenge strain.

PCR analysis of virulence genes
-------------------------------

The variant *H. parasuis* serovar 4-1 and serovar 4-2 strains lack ORFs HPM_1370, HPM_1371, HPM_1372, HPM_1373, HPM_0299 and HPM_0300 reiterating our *in silico* based analysis (Fig [3](#F3){ref-type="fig"}). On the other hand, *H. parasuis* variant serovar 4 strains possess all the three virulence associated trimeric autotransporters *(vtaA*) domains similar to virulent *H. parasuis* serovar 5. Comparative genomic analyses revealed that group 3 vtaA is highly conserved among the invasive and non-invasive strains, while groups 1 and 2 vtaA were detected only in the virulent strains [@B33]. However all three domains were detected in highly virulent serovar 4-1, serovar 4-2, and serovar 5 (Fig. [3](#F3){ref-type="fig"}) as well as in an avirulent serovar 5 strain (data not presented). We speculate that characterization of avirulent and virulent *H. parasuis* strains based of vtaA domains may not be a reliable approach given the complex gene regulation mechanism involved in determining *H. parasuis* virulence.

Other virulence and virulence associated genes
----------------------------------------------

In addition to the known virulence genes, *H. parasuis* serovar 4 and serovar 5 genomes encode a large number of other virulence and virulence associated genes. These include regulation of uptake of metal ions, MerR family transcriptional regulators, macrophage infectivity potentiator-related protein, hemolysin, opacity associated protein, toxin antitoxin system, colicins, cytolethal distending toxin and virulence associated protein D. The complete lists of genes identified in variant H. parasuis serovar 4 strains are listed in [Supplementary Material](#SM1){ref-type="supplementary-material"}: Table 3.

Regulation and uptake of metal ions
-----------------------------------

Like many pathogenic bacteria, the variant *H. parasuis* serovar 4-1, serovar 4-2 strains and serovar 5 have extensive regulatory and protein-coding systems exclusively devoted to maintaining the homeostasis of biologically required metal ions, most of which are acquired from the environment. Of all the metal acquired ions, iron is the primary regulator of many virulence genes. Our findings reveal that the variant *H. parasuis* serovar 4-1, serovar 4-2 and serovar 5 have an extensive protein network to regulate iron uptake. Iron is required by a number of essential metabolic enzymes, including the cytochromes, ribonucleotide reductase, Fe-S cluster biogenesis and activation/regulation of virulence genes but is often an *in vitro* growth limiting factor for pathogenic bacteria due to its low solubility in water at neutral pH [@B34].

Mammalian hosts lack free iron for uptake, since most of it is stored in intracellular or extracellular tightly bound forms like transferrin, lactoferrin, haemopexin and haptoglobin [@B34], [@B35]. Many bacterial outer membrane (OM) receptor proteins like ferroxamine (HPM_2297) bind to lactoferrin or ferritin prior to mediating internal transport. These receptors are usually 22-stranded β-barrel proteins containing extracellular loops which bind substrates, and an N-terminal region or plug, that folds into the barrel near the periplasmic surface [@B36]. Since there are no ionic gradients to drive this transport, transport across the OM is coupled to the proton motive force of the cytoplasmic membrane via a periplasm-spanning complex like TonB, ExbB and ExbD [@B37]. The *H. parasuis* periplasm-spanning complex is composed of TonB (HPM_0089 and HPM_0090), ExbB (HPM_0091), and ExbD (HPM_0092). Once in the periplasm, the uptake of Fe (III) or Fe (III)-chelate occurs through the transmembrane channel of ATP-binding cassette (ABC) transporters found in the plasma membrane, in a process mediated by ATP hydrolysis [@B38]. *Haemophilus parasuis*serovar 4 and serovar 5 also possess three heme binding proteins (HPM_0689 HPM_2386, HPM_0785) which bind to heme and hemin and are involved in iron acquisition. Variant *H. parasuis* serovar 4 also encodes iron-binding protein IscA (HPM_1829), which transfers intracellular free iron to iron-sulfur clusters to apo-ferredoxin, iron utilization protein hugX (HPM_0784), ferric iron reductase (HPM_1543), involved in ferric hydroximate transport, very high affinity iron scavenging proteins hemopexin B and A (HPM\_ 1235, HPM_1236), two periplasmic iron uptake and binding protein (HPM_1161 and HPM_1150), ferric transporter ATP-binding subunit (HPM_1466), high affinity heme/hemopexin utilization protein C/outer membrane receptor protein to transport Fe ions (HPM_1031) and ferric uptake regulation protein (HPM_1051). The heme exporter protein B (HPM_2191) which exports heme to the periplasm for the biogenesis of c-type cytochromes is adjacent to cytochrome c biogenesis ATP-binding export protein CcmA (HPM_2192).

*Haemophilus parasuis* serovars 4 and serovar 5 encode two outer membrane TonB dependent receptors or iron regulated outer membrane proteins, IROMP (HPM_0168, HPM_0415). Encoded in *H. parasuis* serovar 5 and serovars 4 are three small multifunctional proteins, frataxin (HPM_1028), ferredoxins (HPM_0902) and Ferritin/ DNA-binding stress protein (HPM_2074). Frataxin acts as an iron chaperone during cellular heme and iron-sulfur (Fe-S) cluster production, scavenges iron and stores iron during iron overload, repairs oxidatively damaged aconitase Fe-S clusters, reduces oxidative stress by moderating the concentration of reactive oxygen species (ROS) and is involved in energy conversion and oxidative phosphorylation [@B39]-[@B42].

Thus, *H. parasuis* serovar 4-1, serovar 4-2 and serovar 5 genomes encode a large number of proteins with overlapping functions involved in maintaining iron homeostasis, indicating the critical role of iron in *H. parasuis* pathogenesis. These proteins could also possibly be targeted to develop universal vaccines or for strain identification.

In addition to iron, *H. parasuis* requires metal ions like molybdenum, zinc, copper, nickel, and magnesium for the activation of many metallo-proteases, metabolic enzymes and DNAse. *H. parasuis* serovar 4-1, serovar 4-2 and serovar 5 has an extensive network of proteins to acquire these metals which include molybdenum cofactor biosynthesis (HPM\_ 0200), molybdoprotein biosynthesis protein, molybdoprotein biosynthesis MoeB and two MoeA (HPM_0201, HPM_1239 and HPM_1012), moylbdate ATP transporter (HPM_1718), molybdate ABC transporter (HPM_1719), molybdenum transport protein (HPM_0692), molybdate-binding periplasmic protein (HPM_0693), molybdenum cofactor biosynthesis protein C\' (HPM_0289), molybdopterin converting factor (HPM_0290). In addition, zinc ABC transporter (HPM_0361, HPM_1198), high-affinity zinc transporter periplasmic component (HPM_0485), zinc/copper dismutase (HPM_0873), copper homeostastsis (HPM_1035), nickel transport permease (HPM_2246), nickel-binding periplasmic precursor protein, nikA (HPM_0691), ABC-type nickel/cobalt efflux system, permease component (HPM_2454), Mg^2+^/Co^2+^ transporter (HPM_2352), magnesium dismutase (HPM_1717), and magnesium transport corA protein (HPM\_ 0841).

MerR family of transcriptional regulators
-----------------------------------------

The regulation of metal ion homeostasis is exclusively controlled by MerR family of transcriptional regulators [@B43]. MerR family of regulators have been exclusively found in eubacteria but not yet identified among archaebacteria or eukaryotes [@B43]. MerR transcriptional regulators function nearly exclusively as transcriptional activators of gene expression, and are required for metal efflux or detoxification, defense against oxidative, biotic or abiotic stress and provide drug resistance [@B44].

In *H. parasuis* serovars 4 and serovars 5, MerR regulator (HPM_1347) is a 15.7 kDa protein and belong to a helix-turn-helix (HTH) MerR-SF superfamily. *Haemophilus parasuis* MerR is similar to other bacterial MerR regulatory proteins and follow a canonical N-terminal HTH-DNA binding domain which is about 40 amino acids long and a C-terminal metal-coordinating domain (between 80-130 amino acids) that is specific to the metal ion recognized [@B45], [@B46]. The MerR families of metal-binding and metal-responsive proteins are unique in that they activate transcription from unusual promoters with a high spacing of 19 bp between the-35 and-10 sequences [@B45]. These cytoplasmic transcription factors bind metal ions through cysteine or histidine residues [@B46]. Although different bacteria and have a common design i.e. conserved primary structure, they can effectively discriminate metals *in vivo* [@B47]. Based on NCBI database (<http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi?RID=1A9YCPJB014&mode=all>) analysis (E-value: 7.89e-39) *H. parasuis-* Mer R regulator appears to be a heavy metal (copper, cadmium, lead, zinc) resistance transcription regulator.

The presence of these extensive metal acquisition genes along with a specific transcriptional regulator exhibits a very complex gene regulation mechanism involved in the expression of *H. parasuis* virulence genes.

Macrophage infectivity potentiator-related protein
--------------------------------------------------

Macrophage infectivity potentiator (MIP)-related proteins have been identified in many pathogenic bacteria such as *Neisseria*, *Actinobacillus*, *Legionella*, Chlamydia and in faculatively intracellular pathogens like *Coxiella burnetii* and *Burkholderia pseudomallei* and the protozoan parasite, *Trypanosoma cruzi* [@B48]-[@B51]. Variant *H. parasuis* serovars 4 and serovar 5 genomes encode a putative macrophage infectivity potentiator-related protein (HPM_0216), which is a 20 kDa outer membrane protein. Our analyses (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) shows that *H. parasuis* serovars 4 and serovar 5 MIP belong to the carboxymuconolactone decarboxylase (CMD) superfamily (COG2128), exhibiting a multidomain architecture similar to other pathogenic bacteria.

*Haemophilus parasuis* serovar 5 and serovars 4 MIP contain overlapping alkylhydroperoxidase AhpD family core domain, alkylhydroperoxidase domain protein, Avi_7169 family and a gamma-carboxymuconolactone decarboxylase. Like the rest of the prokaryotic MIP-like proteins, the predicted N- terminal structure of *H. parasuis* serovars 4 and serovar 5 MIP contain three large alpha-helices followed by a short beta-sheet or turn.

*Burkholderia pseudomallei* MIP-like protein is sensitive to immunosuppressants like FK506 and rapamycin which abolish its peptidylprolyl isomerase activity. *Burkholderia pseudomallei* mutants lacking MIP exhibit reduced ability to survive within cells and are significantly attenuated *in vivo* [@B50]. In addition, MIP plays a vital role in Chlamydia spp. entry into McCoy cells [@B48]. A similar function for *H. parasuis* MIP cannot be ruled out and may aid in intracellular invasion and survival of the bacteria. MIP-like proteins could potentially serve as a target for universal vaccine.

Hemolysin
---------

Hemolysins are toxic to erythrocytes, but some bacterial species produce hemolysins which lyse leukocytes as well [@B52]-[@B56],[@B59]. The variant*H. parasuis* serovar 4-1, serovar 4-2 and serovar 5 have two hemolysin activation/secretion proteins (HPM_2302, HPM_1788) and two hemolysin structural proteins (HPM_1789, HPM_2290). The ORFs HPM_1788 and HPM_1789 are adjacent to each other, similar to those found in *H. ducreyi* (*hhdB*and *hhdA*), *Serratia marcescens* (*shlB* and *shlA*), *Proteus mirabilis* (*hpmA* and *hpmB*) and *Edwardsiella tarda*. However, ORFs HPM\_ 2302 and HPM_2290 are not adjacent. In addition *H. parasuis* serovars 4 and serovar 5 genomes also encode AphA-like protein/membrane protein affecting hemolysin expression (HPM_2138), a 21 kDa hemolysin precursor protein (HPM_0599) and another possible hemolysin structural protein (HPM_0082). Earlier studies have shown that the *S. marcescens*, ShlB is an outer membrane protein which is required for secretion and activation of the hemolysin structural protein, ShlA [@B57],[@B58]. Once secreted, ShlA interacts with target cell membranes, oligomerizes, and forms pores on the cell membrane resulting in target cell lysis similar to other members of the "RTX" toxin family indicating a similar function in *H. parasuis.*

Opacity associated protein
--------------------------

Opacity-associated proteins (OapA and OapB) have been implicated in phase variation, adhesion to epithelial cells during initial colonization and cell invasion in H. influenza, and Neisseria gonorrheae [@B60], [@B61]. H. parasuis serovar 5 and serovars 4 strains encode two OapA and OapB proteins (HPM\_ 0924, HPM_0925) which help in the initial colonization and adhesion along with fimbriae/adhesins and pili complex loci ( HPM_0366, HPM_0367, HPM_0368, HPM_0371, HPM_1452, HPM_1455 and HPM_1637).

Toxin-antitoxin system
----------------------

*Haemophilus parasuis*serovars 4 and serovar 5 genomes encode numerous toxin-antitoxin systems (TAS) which are abundant, diverse, horizontally mobile genetic elements [@B62]-[@B64]. Toxin-antitoxin systems are frequently limited to bacterial and archaeal genomes and are involved in a variety of functions including plasmid stabilization, transcription regulation, enhancing resistance mechanisms and RNA-interference [@B63]-[@B65]. *Haemophilus parsuis*serovars 4 and serovar 5 TAS help prevent hostcell-death by a group of protein/antitoxins of the toxin-antitoxin stability system (HPM_1007). These include the antitoxin/toxin system zeta toxin, signal recognition particle GTPase protein (HPM_1145), fic family toxin-antitoxin (HPM_1182), addiction module antitoxin/putative RelE toxin-like protein, plasmid stabilization system (HPM_1184), toxin component, RelE family (HPM_0312), transcriptional regulator/antitoxin, MazE protein (HPM_1226), antitoxin ChpS/ transcriptional regulator/antitoxin, MazE/ putative plasmid stable inheritance protein (HPM_1862), growth inhibitor, PemK-like, autoregulated/transcriptional modulator of MazE/toxin, MazF, plasmid stable inheritance protein K protein (HPM_1863), plasmid stability protein StbD, (HPM_2272), HicA and B (HPM_2185, HPM_0011 and HPM_0012). The number of modules in a TAS may range from one to eight [@B66],[@B67]. However, most of the regulated TAS are two-component systems and function similar to HicA and HicB.

The ORFs HicA and B (HPM_0011 and HPM_0012) are contiguous and attached to competence protein comM (HPM_0013), whereas another HicA (HPM_2185) is associated with an endonuclease (HPM_2184). The HicB protein has a partially degraded RNAse H fold, whereas HicA has a double-stranded RNA-binding domain [@B68]. The stable combination of these two domains suggests transcription regulation mediated through RNA, most likely by RNA binding-degradation (RNA interference, RNAi) mechanism. In most HicB proteins, the RNAse H-like domain is fused to a DNA-binding domain, of the ribbon-helix-helix or to the helix-turn-helix motif [@B68]. TheTAS proteins containing these DNA-binding domains function as antitoxins [@B68]. *Haemophilus parasuis* serovars 4 and serovar 5 strains have numerous TAS genes located within their pathogenicity islands that are amenable for horizontal transfer and function as accessories to chief virulence genes similar to pathogenic bacteria.

Virulence associated protein D
------------------------------

*Haemophilus parasuis* serovars 4 and serovar 5 genomes encode virulence associated protein D (VapD), (HPM_1572) which shares 100% identity to VapD of a serovar 5 *H. parasuis* SH0165 (YP_002476324), *H. parasuis* ZJ0906 (YP_008124455) and *H. parasuis* SW114 (EQA00157.1). However, they are only 90% identical to *Actinobacillus minor* (WP_005826028), 64% to *Neisseria lactamica* (WP_003711106.1), 63% to *N. meningitides*(WP_002238271.1), and 62 % to CRISPR associated Cas2 family protein of *N. meningitides* (WP_002251489).

*Rhodococcus equi* contains a highly characterized *vap*D gene found on an 80-90 kb virulence plasmid which contains a 27.5 kb pathogenicity island encoding a family of seven Vap proteins including VapA-G [@B69], [@B70]. *Rhodococcus equi* mutants lacking 7.9 kb DNA region spanning five *vap*genes (*vap*A, -C, -D, -E and -F) are avirulent and are rapidly cleared by the mouse immune system compared to wild type [@B70]. Furthermore, *R. equi* isogenic plasmid-cured mutant strains lose their ability to survive in alveolar macrophages and fail to induce pneumonia in foals [@B71],[@B72]. The *vap* genes are also induced by H~2~O~2~[@B73]. The VapD protein along with macrophage infectivity potentiator may also be involved in initiating and maintaining *H. parasuis*intracellular infection, especially within macrophages. Therefore, these antigens could be incorporated in a novel vaccine development strategy.

Colicin
-------

Colicins are heat-labile proteins first identified in certain strains of *E. coli* that harbor a single colicinogenic plasmid [@B74]. Since this report, colicins have been identified in many bacterial strains which are antagonistic to other closely related strains. Colicinogenic strains of pathogenic bacteria are widely distributed in nature and are particularly abundant in the animal intestinal tracts [@B75].

*Haemophilus parasuis*serovars 4 and serovar 5 colicins, like other bacteria, are not synthesized under normal conditions since the colicin operon is repressed by the LexA protein (HPM_1027). *Haemophilus parasuis*serovars 4 and serovar 5 encode colicin V (HPM_1084) and a colicin transport protein TolQ (HPM_1307) conferring a competitive advantage to strains occupying nasal cavities and upper respiratory tracts of the pigs.

Cytolethal distending toxins
----------------------------

Cytolethal distending toxins (CDT) are heterotrimeric toxins and have been identified in various Gram-negative bacteria including Campylobacter spp, E. coli, H. ducreyi, A. actinomycetemcomitans, S. dysenteriae, and Helicobacter spp. [@B76]-[@B81]. Upon entry into the target cells, CDTs randomly nick cellular DNA leading to apoptosis [@B82]. These toxins also trigger G2/M cell cycle arrest in specific mammalian cell lines leading to enlargement of distended cells that result in necrosis [@B83]. This toxin is internalized via the Golgi complex and transported to the endoplasmic reticulum in a retrograde fashion similar to Cholera Toxin A1 [@B84]. Cytolethal distending toxin production is dependent on the expression of three (cdtA, cdtB, and cdtC) contiguous genes in the operon [@B85], [@B86].

Haemophilus parasuis H. serotypes 4 and H. serotype 5 genomes contain one gene encoding CDT internalizing protein, cdtA (HPA_2217), but lack the active toxin cdtB and an internalizing protein, cdtC. The possible reasons for missing cdtB and cdtC genes are, either due to a gap in the map-based assembly or they may truly lack a functional CDT operon. If this is the case, H. parasuis would have similarities to Campylobacter spp. strains lacking CDT that cause enteric diseases in human [@B87].

Unmapped genes
--------------

Analysis of the unmapped regions yielded a total 263 genes for serovar 4-1 and 323 genes for serovar 4-2 [Supplementary Material](#SM1){ref-type="supplementary-material"}: Tables 4 and 5). Open reading frames (ORFs) less than 300 bp are usually repeats and often do not encode functional proteins. Therefore a cut off value of 300 bp was set and ORFs ≥300 bp were mapped and annotated. This resulted in 190 ORFs for serovar 4-1 and 237 ORFs for serovar 4-2 respectively. The unmapped regions of serovar 4-1 and serovar 4-2 contain horizontal gene transfer elements, hypothetical proteins, transcription factors, phage genomes, transporters, housekeeping genes (cell wall/LPS biosynthesis) and a toxin antitoxin protein zeta toxin. However, the uniqueness of these genes to each strain could not be verified since this was a map-based assembly on draft genomes.

In summary, the comparative genomic analysis presented here clearly indicates the variant *H. parasuis* serovar 4-1 and serovar 4-2 strains have extensive LOS and OMP structural modifications that aid in nasal colonization, host immune evasion and possibly serum-resistance. In addition, the lack of sialic acid residues on serovar 4-1 and serovar 4-2 LOS may lead to a "cytokine storm" resulting in septicemia, pulmonary edema and severe pneumonia as evidenced by the lung pathology. When piglets were challenged with variant *H. parasuis* serovars 4, 50% died within 48 h indicating the highly virulent nature of the variant serovar 4 strains. The variant *H. parasuis* serovar 4 strains also harbors a more diverse repertoire of virulence associated genes than previously described. The combination of capsule modification and phase variation due to LOS substitutions could help variant *H. parasuis* serovar 4 escape host immune system and possibly transform into a deadly pathogen and lead to a disease outbreak.

Methods
=======

Bacterial isolates and genomic DNA sequencing
---------------------------------------------

The *H. parasuis* serovar 4 (strains were isolated by the Newport Laboratories and dubbed as *H. parasuis* serovar 4-1 and *H. parasuis* serovar 4-2. *Haemophilus parasuis* was cultured on Trypticase Soy Agar (TSA) plates supplemented with 5% bovine serum and 10 mg/ml nicotinamide adenine dinucleotide (NAD) at 37ºC in 5% C0~2~ for 36 hours. Following incubation the bacterial cells were removed from the plate with sterile PBS and washed twice with PBS prior to DNA extraction.

Genomic DNA from *H. parasuis* serovar 5 wild type (Bioproject accession PRJNA218837) and serovar 4 strains was extracted using bacterial genomic DNA isolation kit (Edge Biosystems, Gaithersburg, MD, USA). The quality of the genomic DNA was determined by PicoGreen (Life Technologies, Grand Island, NY, USA). The genomic DNA library was generated using a TruSeq^®^ Library preparation kit (Illumina Inc., San Diego, CA, USA) following the manufacturer\'s recommendation and sequenced on Illumina HiSeq 2000 to obtain on 50 bp PE reads. Whole genome sequencing was performed at the University of Minnesota Genomics Center. Allll the *H. parasuis* strains isolated in this study were confirmed by the Department of Veterinary Medicine, University of Montreal, Montreal, Canada.

Sequence Analysis
-----------------

*Haemophilus parasuis* serovar 5 GenBank isolate SH0165 (GenBank accession number CP001321.1, 88) was used as the reference genome to assemble and map *H. parasuis* serovar 5(Bioproject accession PRJNA218837). Concatenated genome of *H. parasuis* serovar 5 was used to perform comparative genomic analysis *H. parasuis* serovar 4-1 and serovar 4-2 variants. The web based software ABACAS (<http://abacas.sourceforge.net/>) was used to align the SH0165 contigs generated and identify putative gap sizes, orientation, and order of contigs. A custom Python script was used to concatenate contigs, fill the gaps with N\'s, and transfer the annotations. Additional annotations were added to the resulting sequence to highlight gaps, and to label the original contigs. The contigs which could not be aligned against the reference genome were included at the end of the concatenated sequence.

The reads were filtered for quality and Illumina TruSeq adapters using an in-house script which removed reads with 5 or more bases that had a PHRED Quality value \<30. Because of very high coverage, duplicate reads were expected and reads were only analyzed if at least two duplicates existed. A maximum of 10 duplicates were kept for each read. Following quality filtering, reads were mapped against SH0165 and a concatenated set of contigs was aligned and oriented using SH0165 as a reference.

Consensus GenBank formatted sequences for each serovar 4 isolate were generated by mapping reads against serovar 5 WT (Bioproject Accession: PRJNA218837) using Bowtie 2 and then calling a mapping consensus using Samtools. Annotations from serovar 5 WT were then copied to the new serovar 4 consensus sequence. Reads were mapped for each isolate using Bowtie2 v 2.0.6 (<http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>) and default primers against *H. parasuis* serovar 5. . Filtering was then carried out to remove multiple mapped reads and MAPQ \<10 using a custom script. Based on the mapping results, SAMtools (<http://samtools.sourceforge.net/> ) was employed to generate the consensus sequences. This sequence data was annotated using the reference sequence and formatted as a GenBank file for Artemis compatibility using custom scripts and BioPython. (<http://biopython.org/wiki/Biopython>).

The reads which could not be mapped to the GenBank reference strain, by Bowtie2, were identified and assembled using the Newbler v2.6^®^ software (GS de novo Assembler, Roche). The gene prediction program Prodigal v2.6 (<http://prodigal.ornl.gov/>) was used to predict genes from the assembled contigs. Putative genes were assigned anannotation using tool BLANNOTATOR (<http://www.biomedcentral.com/1471-2105/13/33>).

Mapping coverage was calculated for each position in reference using SAMtools. Gene annotation information was used to calculate the percentage of bases which had coverage for each gene. Genes in which less than 80% of bases had coverage were called absent and classified as unmapped genes.

Finally, unmapped reads were assembled using Newbler v2.6^®^, putative genes determined using Prodigal, and annotated using the software tool BLANNOTATOR (<http://www.biomedcentral.com/1471-2105/13/33>).

PCR Analysis of Capsule and Putative Virulence Genes
----------------------------------------------------

Genomic DNA from all the 3 strains was extracted using the bacterial genomic DNA isolation kit (Edge Biosystems, Gaithersburg, MD, USA). Polymerase chain reaction (PCR) assay\'s specific for *H. parasuis* serovar 4 and serovar 5 genes were performed using the set of primers described in Table [1](#T1){ref-type="table"}. Polymerase chain reaction assays were carried out in a final, 25 µl volume with GoTaqH PCR SuperMix^®^ (Promega Inc., Madison, WI, USA) with 0.2 mM of each primer and 10 ng of genomic DNA from each isolate respectively. The PCR cycling conditions consisted of an initial denaturation at 95 ºC for 5 min followed by 35 cycles of denaturation at 95 ºC for 30 sec, annealing at 55 ºC for 30 sec, and extension at 68 ºC for 1 min, and a final elongation at 72 ºC for 5 min. All PCR products were visualized after electrophoresis in 1.0% agarose gels run at 7.0 V/cm by staining with ethidium bromide.

Sialic acid assay
-----------------

*Haemophilus parasuis*cultures were grown as described above and heat inactivated. Briefly the bacteria removed from the culture plate, harvested by centrifugation (8,000 x g for 10 min) and washed three times with phosphate-buffered saline (1X PBS), pH 7.2, to remove secreted proteins and resuspended in PBS. Serial tenfold dilutions were made and plated on Trypticase Soy Agar plates to determine the number of colony forming units (CFU) per ml. Bacterial suspensions were heat inactivated at 60°C for 1 h and plated again to confirm heat inactivation. The cell suspension was adjusted to10^10^CFU/ml. Fifty microliter aliquots of the inactivated bacterial cultures were treated with 0.5 U of neuramidinase (Sigma, St. Louis, MO, USA) and incubated for an hour at 37˚C before proceeding with the sialic acid quantitation assay ([@B15]. The sialic acid assay was performed using QuantiChrom^®^ sialic acid assay kit (BioAssay Systems, Hayward, CA, USA) following the manufacturer\'s recommendations. Sialic acid standards provided with the kit were used to derive a standard curve and the amount of sialic acid released from lipooligosaccharide (LOS) was expressed as µM.
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![Agarose gel electrophoresis of *H. parasuis* serovar 4-1, serovar 4-2 and *H. parasuis* serovar 5 wild type using primers listed in Table [1](#T1){ref-type="table"}. Lanes 1 & 32, Molecular weight markers; Lanes 2, 5, 8, 11, 14, 17, 20, 23, 26 & 29, PCR products from serovar 5 WT; Lanes 3, 6, 9, 12, 15, 18, 21, 24, 27 and 30, PCR products from serovar 4-1; Lanes 4, 7, 10, 13, 16, 19, 22, 25, 28 & 31, PCR products from serovar 4-2.](jgenv03p0059g003){#F3}

###### 

List of primer pairs used to amplify virulence and virulence associated genes from *H. parasuis* serovar 4-1, serovar 4-2 and *H. parasuis* serovar 5 wild type.

  Primers      Sequence (5\'→3\')                Product (bp)                    Amplicon
  ------------ --------------------------------- ------------------------------- ----------
  0610 FOR     ATGAATTTGATTATTTGTATGACTCCATTTC   Sialyltransferase               969
  0610 REV     CTATTGGCATGTGTAGTCAATTACTTC                                       
  0300 FOR     ATGTTAATGCCATTAATTTATTCATTG       CapD protein                    780
  0300 REV     TCGAACCGATAGAACCAGCAGCACCAGTC                                     
  0299 FOR     ATGTGTAAGTTAACTAAAGCTCTTG         Polysaccharide export protein   840
  0299 REV     AGCAATTGCTTCGGTTAACGTCATAC                                        
  1370 FOR     ATGCTAAAAAGAGTGTTTGATATTTTC       Glycosyl transferase            540
  1370 REV     TATATTATGATTAACATAATC                                             
  1371 FOR     ATGAACTTTCTACCATTCGCCCTTCCCG      Glycosyl transferase            520
  1371 REV     ATTATATTTGAATCCAGGTTCAATG                                         
  1372 FOR     ATGAAATTGTCTGTCTTAATGGCTGT        Glycosyl transferase            720
  1372 REV     TCCGCCAAATGTACATCATCAC                                            
  1373 FOR     ATGAAATTGTCTGTCTTAATGGCTGT        Glycosyl transferase            462
  1373 REV     CTCTCATACCATACCCCAACTCAGG                                         
  YADAF1^\*^   TTTAGGTAAAGATAAGCAAGGAAATCC       vta (PCR1)                      406
  PADHR1^\*^   CCACACAAAACCTACCCCTCCTCC                                          
  YADF2^\*^    AGCTTATATTCTCAGCACAAGGTGC         vta (PCR2)                      294
  PADHR2^\*^   CCACTGATAACCTACCCCCACAGAG                                         
  YADAF3^\*^   AATGGTAGCCAGTTGTATAATGTTGC        vta (PCR2)                      293
  PADH3^\*^    CCACTGTAATGCAATACCTGCACC                                          

\* Olvera A, Pina S, Macedo N, Oliveira S, Aragon V, Bensaid A. Identification of potentially virulent strains of *Haemophilus parasuis* using a multiplex PCR for virulence-associated autotransporters (vtaA). Vet J. 2012 191[@B2]:213-218.
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